General Information of the Compound
Compound ID
CP0576523
Compound Name
1-benzhydryl-4-[4-(2-methylimidazol-1-yl)butyl]piperazine
    Show/Hide
Structure
Formula
C25H32N4
Molecular Weight
388.559
Canonical SMILES
Cc1nccn1CCCCN1CCN(CC1)C(c1ccccc1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C25H32N4/c1-22-26-14-17-28(22)16-9-8-15-27-18-20-29(21-19-27)25(23-10-4-2-5-11-23)24-12-6-3-7-13-24/h2-7,10-14,17,25H,8-9,15-16,18-21H2,1H3
    Show/Hide
InChIKey
LFJXIZLNMVMVGB-UHFFFAOYSA-N
Physicochemical Property
logP
4.37892
Rotatable Bonds
8
Heavy Atom Count
29
Polar Areas
24.3
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168293526
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01449, P2X purinoceptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000186 RPMI-8226 Homo sapiens (Human)  1
1
IC50 = 3400 nM
   TI
   LI
   LO
   TS